The value of near patient testing is
proven. It reduces costs and improves
the care patients receive.

EARLY DIAGNOSIS & TREATMENT

Physicians across the United States share their knowledge on the importance of
near patient (in-office) clinical testing to their medical practice and the implications
to patient care if they are no longer able to provide these services.

NEAR PATIENT TESTING SAVES LIVES IN RURAL COMMUNITIES

“The results would have been too late. The patient would have died without it.”
Clinician, Rural Kentucky Community

Physicians in rural communities share their views on the value of the near patient testing in their communities as well
as the impact on elderly patients. This research study reveals the unique challenges of elderly patients residing
in our most rural communities in accessing clinical laboratory services.

TRENDING

In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to direct the Centers for Medicare and Medicaid Services (CMS) to develop a market-based methodology for determining the future rates Medicare will pay for tests under the Clinical Laboratory Fee Schedule (CLFS). The centerpiece of the methodology is for CMS to gather data from laboratories nationwide on the payments they receive from the private insurance market.

A deeper analysis shows that the current data collection and evaluative pricing methodology, if fully implemented, will jeopardize patient access to laboratory testing in clinics and small community independent laboratories.  The cuts in Medicare rates for the common tests that clinicians use every day to treat patients will be to a level that providers may simply stop performing laboratory services.

PDF download: Primer on PAMA

NEAR PATIENT TESTING
DURING AN OUTBREAK

Our interconnected society makes it vital that our public health professionals get quick, real-time access to diagnostic information when the next epidemic disease breaks out so they can quickly identify the disease and a possible treatment. Physicians who provide laboratory services in their practice are able to rule out other potential infections fast in their own laboratory while the patient waits.  If the infection is not identifiable, the physician can quickly refer the specimen to a reference laboratory or directly to the public health lab. The faster these diseases are identified, the faster we can treat these patients and the more likely we will save their lives.

RECENT NEWS & EVENTS

VIEW ALL NEWS

TWITTER

EMAIL ALERTS

Enter your email address to receive the latest news and information about Near Patient Testing.

EXPLORATIVE RESEARCH STUDY